A clinical-stage biotechnology company developing blood purification technologies designed to remove pathogens, toxins, and disease-promoting particles from the bloodstream. Its lead platform, Sigyn Therapy, is being explored for applications in infectious disease, cancer, and inflammatory condition...
No congressional trades have been disclosed for Sigyn Therapeutics Inc (SIGY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.